Navigation Links
Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
Date:3/11/2008

First-of-its kind, RFID-enabled system addresses complex issues associated

with the utilization of contrast media

WAYNE, N.J., March 11 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, unveiled plans to launch VistaTrak(TM), an innovative contrast media management system that provides radiology departments with a new and powerful management tool to help enhance patient care and safety, optimize inventory management and improve billing accuracy.

VistaTrak is a collaboration between Bayer HealthCare Pharmaceuticals and Mobile Aspects, an industry leader in providing Radio Frequency Identification (RFID)-enabled solutions for healthcare and hospital environments. The companies worked together to optimize Mobile Aspects' proprietary iRIS(TM) platform for the unique needs and requirements of the radiology environment. Bayer is the first company to offer a contrast media management system based on an RFID platform to automate manual processes and capture valuable operational data that currently cannot be found in any one system.

The VistaTrak contrast media management system was previewed at the 2007 Radiological Society of North America (RSNA) 93rd Scientific Assembly and Annual Meeting last November, where it was well-received. The system combines RFID technology of "tagged" bottles of contrast agent with a "smart" cabinet and a specially designed interface to capture, store and manage product utilization data easily and reliably while helping to reduce the risk of human error. It helps radiology departments and administrators by providing radiology-specific solutions for the use of contrast media, such as:

-- Facilitating patient safety by automatically screening data from a

patient's electronic medical record (EMR) for, among other things,

contraindications and prior adverse events

-- Capturing important information stored on the tag, such as NDC number,

expiration date and lot number, automatically and in an efficient

manner that supports compliance with accrediting organization

requirements

-- Providing accurate contrast dosing information to improve billing

accuracy and help address any existing issues with reimbursement or

audits

-- Tracking inventory to enable departments to order and manage inventory

more efficiently and reduce waste

VistaTrak features an easy-to-use, touch-screen interface and is available in two different sizes to address varying usage needs.

"Our new, cutting-edge VistaTrak system addresses some of the most pressing concerns confronting radiology departments today, such as patient safety and the increasing requirements by accrediting organizations on the storage, handling and use of contrast media," said Douglas Stefanelli, Vice President and General Manager, Diagnostic Imaging, Bayer HealthCare Pharmaceuticals. "This is the first time RFID technology is being employed in this unique way in the radiology suite, and is an example of how Bayer HealthCare continues to innovate in radiology and helps improve patient care."

"Collaborating with Bayer HealthCare Pharmaceuticals to help address challenges in the radiology setting has provided us with another opportunity to showcase the versatility and benefits of our advanced and patented RFID- based systems in a hospital and healthcare environment," said Suneil Mandava, President and Chief Executive Officer, Mobile Aspects. "Mobile Aspects is looking forward to working with Bayer in supporting VistaTrak and its ability to help radiology departments more effectively manage risk and potentially improve the business processes in all departments that touch contrast media."

About Bayer HealthCare Pharmaceuticals

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals unit of Bayer HealthCare LLC, a division of Bayer AG. One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. In the United States, Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

About Mobile Aspects

Mobile Aspects, Inc. of Pittsburgh, Pa., is a healthcare technology supplier focused on providing an integrated suite of clinical resource management solutions to automate the management of supply, asset, drug and patient tracking through the One System of CARE solution. The cornerstone of these technological capabilities is Intelligent Radio Frequency Inventory System (iRIS(TM)), the industry's leading patent-protected tracking architecture that leverages radio frequency identification (RFID) technology. Through this innovative technology, clinicians and other care providers experience a hands free approach to managing the resources used in the patient care process.

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
2. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
3. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
4. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
5. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
6. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
7. Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company
8. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
9. BD to Present at Investor Healthcare Conferences
10. Abbott to Present at Lehman Brothers Healthcare Conference
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Susquehanna Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... active R&D program for the development of future natural products ... unique research and development center in Israel ... Stockton has a variety of products ... is active in more than 35 counties worldwide. ... flagship product Timorex Gold ® is used to ...
(Date:2/5/2016)... ATCC, the premier global biological materials resource ... and life science researchers that are working to address ... CDC website . --> CDC ... a single-stranded RNA virus of the Flaviviridae family, genus ... Chikungunya Viruses. Zika virus is transmitted to humans primarily ...
(Date:2/4/2016)... , ... February 04, 2016 , ... ... development and compliance training, today announced an interactive FDA compliance training ... The RAPS (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently ...
(Date:2/4/2016)... Beike Biotechnology, the Shenzhen ... ceremony in late 2015 to mark their successful combined ... --> --> The ... Cell Therapy" was hosted by the Shenzhen Cell Bank ... of Beike Biotechnology Co., Ltd. Shenzhen,s ...
Breaking Biology Technology:
(Date:1/22/2016)... 22, 2016 ... of the  "Global Behavioral Biometric Market ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ... Biometric Market 2016-2020"  report to their ... Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ...
(Date:1/21/2016)... January 21, 2016 ... new market research report "Emotion Detection and Recognition Market by ... Tools (Facial Expression, Voice Recognition and Others), Services, ... forecast to 2020", published by MarketsandMarkets, the global ... reach USD 22.65 Billion by 2020, at a ...
(Date:1/20/2016)... Jan. 20, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce the ... achievements are the result of the company,s laser focus ... eClinical , it,s comprehensive, easy-to-use and highly affordable ... --> Key MedNet growth achievements in 2015 include: ...
Breaking Biology News(10 mins):